Cargando…
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
BACKGROUND: Statins are a class of medications that reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Whether statins can benefit patients with dementia remains unclear because of conflicting results. We hypothesized that some of the confusion in the literature might...
Autores principales: | Wolozin, Benjamin, Wang, Stanley W, Li, Nien-Chen, Lee, Austin, Lee, Todd A, Kazis, Lewis E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1955446/ https://www.ncbi.nlm.nih.gov/pubmed/17640385 http://dx.doi.org/10.1186/1741-7015-5-20 |
Ejemplares similares
-
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
por: Li, Nien-Chen, et al.
Publicado: (2010) -
Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury
por: Li, Mingfei, et al.
Publicado: (2020) -
Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease
por: Oftedal, Linn, et al.
Publicado: (2023) -
The incidence, baseline predictors, and outcomes of dementia in an incident cohort of Parkinson’s disease and controls
por: Counsell, Carl, et al.
Publicado: (2022) -
Simvastatin Reduces Capsular Fibrosis around Silicone Implants
por: Chung, Kyu Jin, et al.
Publicado: (2016)